L. Matthew Posard

Affiliations

  • at Halozyme Therapeutics Inc. (HALO), 2025-05-02
  • Director at Nautilus Biotechnology Inc. (NAUT), 2024-06-17
  • Director at Talis Biomedical Corp (TLIS), 2023-06-12
  • Director at Dermtech Inc. (DMTK), 2023-06-05
  • Chief Commercial Officer at Trovagene Inc. (TROV), 2016-01-06
  • Sr Vp & General Manager at Illumina Inc (ILMN), 2013-05-30
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NAUT $4.45 10,000 $44,493.00 50,000 2021-12-01 Filing
NAUT $4.46 10,000 $44,612.00 40,000 2021-12-01 Filing
NAUT $4.50 10,000 $45,000.00 30,000 2021-12-01 Filing
NAUT $4.57 20,000 $91,400.00 20,000 2021-11-30 Filing
TLIS $16.00 62,500 $1,000,000.00 62,500 2021-02-17 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HALO $57.70 9,881 $570,133.70 69,874 2024-08-14 Filing
HALO $56.19 10,000 $561,930.00 79,755 2024-08-13 Filing
HALO $55.72 10,000 $557,230.00 89,755 2024-08-12 Filing
HALO $50.62 10,000 $506,190.00 99,755 2024-06-12 Filing
HALO $50.01 10,000 $500,110.00 109,755 2024-06-11 Filing